| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.635 | 0.009 | 0.635 | Immunosuppressant | 0.585 0.015 DBMET02122 0.609 0.012 DBMET02123 | ||
| 0.566 | 0.014 | 0.566 | Antioxidant | 0.421 0.031 DBMET02122 0.431 0.03 DBMET02123 | ||
| 0.519 | 0.003 | 0.519 | ABCA1 expression enhancer | 0.219 0.008 DBMET02122 0.386 0.004 DBMET02123 | ||
| 0.496 | 0.007 | 0.496 | Melanin inhibitor | 0.429 0.01 DBMET02122 0.477 0.008 DBMET02123 | ||
| 0.492 | 0.043 | 0.492 | Antibacterial | 0.41 0.072 DBMET02122 0.435 0.062 DBMET02123 | ||
| 0.504 | 0.058 | 0.706 | Caspase 9 stimulant | 0.641 0.031 DBMET02122 0.706 0.023 DBMET02123 | DBMET02123 | |
| 0.478 | 0.033 | 0.706 | Vasodilator, peripheral | 0.706 0.006 DBMET02122 0.702 0.006 DBMET02123 | DBMET02122 | |
| 0.441 | 0.003 | 0.478 | Cholesterol synthesis inhibitor | 0.397 0.004 DBMET02122 0.478 0.003 DBMET02123 | DBMET02123 | |
| 0.454 | 0.028 | 0.454 | Caspase 3 stimulant | 0.311 0.074 DBMET02122 0.373 0.052 DBMET02123 | ||
| 0.434 | 0.018 | 0.486 | DNA synthesis inhibitor | 0.429 0.019 DBMET02122 0.486 0.014 DBMET02123 | DBMET02123 | |
| 0.423 | 0.021 | 0.673 | Hypolipemic | 0.635 0.005 DBMET02122 0.673 0.005 DBMET02123 | DBMET02123 | |
| 0.434 | 0.041 | 0.529 | Immunostimulant | 0.499 0.029 DBMET02122 0.529 0.025 DBMET02123 | DBMET02123 | |
| 0.429 | 0.042 | 0.587 | Antithrombotic | 0.461 0.036 DBMET02122 0.587 0.018 DBMET02123 | DBMET02123 | |
| 0.394 | 0.009 | 0.394 | Alpha-N-acetylglucosaminidase inhibitor | 0.323 0.014 DBMET02122 0.372 0.01 DBMET02123 | ||
| 0.391 | 0.018 | 0.628 | Anesthetic general | 0.628 0.004 DBMET02122 0.57 0.005 DBMET02123 | DBMET02122 | |
| 0.374 | 0.011 | 0.374 | Amylase inhibitor | 0.267 0.024 DBMET02122 0.286 0.02 DBMET02123 | ||
| 0.351 | 0.005 | 0.484 | Succinate dehydrogenase inhibitor | 0.31 0.009 DBMET02122 0.484 0.003 DBMET02123 | DBMET02123 | |
| 0.406 | 0.062 | 0.481 | Transcription factor NF kappa B inhibitor | 0.379 0.068 DBMET02122 0.481 0.047 DBMET02123 | DBMET02123 | |
| 0.327 | 0.005 | 0.328 | Catalase inhibitor | 0.238 0.01 DBMET02122 0.328 0.005 DBMET02123 | DBMET02123 | |
| 0.333 | 0.015 | 0.484 | Gastrin inhibitor | 0.418 0.004 DBMET02122 0.484 0.004 DBMET02123 | DBMET02123 | |
| 0.303 | 0.008 | 0.372 | Neurotrophic factor | 0.372 0.005 DBMET02122 0.317 0.007 DBMET02123 | DBMET02122 | |
| 0.297 | 0.004 | 0.327 | Argininosuccinate synthase inhibitor | 0.173 0.009 DBMET02122 0.327 0.003 DBMET02123 | DBMET02123 | |
| 0.403 | 0.112 | 0.54 | Apoptosis agonist | 0.537 0.064 DBMET02122 0.54 0.063 DBMET02123 | DBMET02123 | |
| 0.323 | 0.033 | 0.486 | Peroxidase inhibitor | 0.466 0.013 DBMET02122 0.486 0.011 DBMET02123 | DBMET02123 | |
| 0.303 | 0.017 | 0.443 | Bone formation stimulant | 0.443 0.008 DBMET02122 0.411 0.009 DBMET02123 | DBMET02122 | |
| 0.284 | 0.006 | 0.381 | Phosphofructokinase-1 inhibitor | 0.259 0.007 DBMET02122 0.381 0.003 DBMET02123 | DBMET02123 | |
| 0.343 | 0.067 | 0.609 | Cholesterol antagonist | 0.502 0.032 DBMET02122 0.609 0.017 DBMET02123 | DBMET02123 | |
| 0.305 | 0.031 | 0.48 | Tyrosine 3 hydroxylase inhibitor | 0.337 0.019 DBMET02122 0.48 0.004 DBMET02123 | DBMET02123 | |
| 0.275 | 0.004 | 0.275 | Papain-like protease (SARS coronavirus) inhibitor | 0.264 0.004 DBMET02122 0.267 0.004 DBMET02123 | ||
| 0.292 | 0.021 | 0.393 | Interferon gamma antagonist | 0.335 0.015 DBMET02122 0.393 0.011 DBMET02123 | DBMET02123 | |
| 0.283 | 0.016 | 0.299 | Phospholipase A2 inhibitor | 0.216 0.035 DBMET02122 0.299 0.014 DBMET02123 | DBMET02123 | |
| 0.291 | 0.054 | 0.291 | Superoxide dismutase inhibitor | 0.233 0.087 DBMET02122 0.247 0.076 DBMET02123 | ||
| 0.311 | 0.079 | 0.363 | Apoptosis antagonist | 0.206 0.171 DBMET02122 0.363 0.05 DBMET02123 | DBMET02123 | |
| 0.232 | 0.003 | 0.232 | Factor V inhibitor | 0.103 0.063 DBMET02123 | ||
| 0.256 | 0.035 | 0.348 | Neurotrophic factor enhancer | 0.348 0.009 DBMET02122 0.301 0.018 DBMET02123 | DBMET02122 | |
| 0.225 | 0.008 | 0.246 | Antineoplastic alkaloid | 0.239 0.005 DBMET02122 0.246 0.005 DBMET02123 | DBMET02123 | |
| 0.22 | 0.009 | 0.267 | Triose-phosphate isomerase inhibitor | 0.189 0.012 DBMET02122 0.267 0.006 DBMET02123 | DBMET02123 | |
| 0.3 | 0.092 | 0.369 | Calcium channel activator | 0.348 0.051 DBMET02122 0.369 0.039 DBMET02123 | DBMET02123 | |
| 0.332 | 0.132 | 0.452 | 5 Hydroxytryptamine release inhibitor | 0.452 0.051 DBMET02122 0.448 0.053 DBMET02123 | DBMET02122 | |
| 0.29 | 0.096 | 0.497 | Vasodilator, coronary | 0.497 0.016 DBMET02122 0.368 0.047 DBMET02123 | DBMET02122 | |
| 0.242 | 0.054 | 0.275 | Nitric oxide antagonist | 0.254 0.05 DBMET02122 0.275 0.045 DBMET02123 | DBMET02123 | |
| 0.215 | 0.036 | 0.393 | Lipid peroxidase inhibitor | 0.393 0.01 DBMET02122 0.331 0.015 DBMET02123 | DBMET02122 | |
| 0.193 | 0.016 | 0.193 | Protease inhibitor | 0.154 0.027 DBMET02122 0.179 0.019 DBMET02123 | ||
| 0.26 | 0.084 | 0.394 | 5 Hydroxytryptamine release stimulant | 0.394 0.047 DBMET02122 0.344 0.058 DBMET02123 | DBMET02122 | |
| 0.199 | 0.025 | 0.199 | Proteasome inhibitor | 0.172 0.035 DBMET02122 0.173 0.035 DBMET02123 | ||
| 0.177 | 0.005 | 0.28 | Glycine receptor agonist | 0.235 0.003 DBMET02122 0.28 0.003 DBMET02123 | DBMET02123 | |
| 0.178 | 0.007 | 0.264 | Interferon agonist | 0.264 0.004 DBMET02122 0.214 0.005 DBMET02123 | DBMET02122 | |
| 0.222 | 0.053 | 0.306 | Hepatoprotectant | 0.232 0.049 DBMET02122 0.306 0.028 DBMET02123 | DBMET02123 | |
| 0.171 | 0.002 | 0.229 | Vitamin D receptor antagonist | 0.229 0.002 DBMET02122 0.188 0.002 DBMET02123 | DBMET02122 | |
| 0.189 | 0.024 | 0.246 | Aminopeptidase B inhibitor | 0.174 0.028 DBMET02122 0.246 0.013 DBMET02123 | DBMET02123 | |
| 0.198 | 0.035 | 0.23 | Arachidonic acid antagonist | 0.224 0.015 DBMET02122 0.23 0.012 DBMET02123 | DBMET02123 | |
| 0.167 | 0.006 | 0.167 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.177 | 0.017 | 0.177 | TRPA1 agonist | 0.127 0.05 DBMET02123 | ||
| 0.217 | 0.059 | 0.378 | Non-steroidal antiinflammatory agent | 0.297 0.029 DBMET02122 0.378 0.016 DBMET02123 | DBMET02123 | |
| 0.174 | 0.019 | 0.203 | Adenylate kinase inhibitor | 0.125 0.04 DBMET02122 0.203 0.015 DBMET02123 | DBMET02123 | |
| 0.164 | 0.015 | 0.211 | Electron transport complex I inhibitor | 0.211 0.007 DBMET02122 0.172 0.013 DBMET02123 | DBMET02122 | |
| 0.156 | 0.015 | 0.172 | Anabolic | 0.161 0.013 DBMET02122 0.172 0.009 DBMET02123 | DBMET02123 | |
| 0.161 | 0.022 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 DBMET02122 0.177 0.008 DBMET02123 | DBMET02122 | |
| 0.152 | 0.015 | 0.443 | Glutamate dehydrogenase inhibitor | 0.15 0.016 DBMET02122 0.443 0.004 DBMET02123 | DBMET02123 | |
| 0.163 | 0.027 | 0.234 | Vanilloid 1 agonist | 0.234 0.006 DBMET02122 0.229 0.007 DBMET02123 | DBMET02122 | |
| 0.139 | 0.003 | 0.156 | Glucose-6-phosphate isomerase inhibitor | 0.13 0.003 DBMET02122 0.156 0.002 DBMET02123 | DBMET02123 | |
| 0.136 | 0.005 | 0.498 | Aconitate hydratase inhibitor | 0.153 0.004 DBMET02122 0.498 0.001 DBMET02123 | DBMET02123 | |
| 0.164 | 0.04 | 0.164 | Aldehyde dehydrogenase inhibitor | 0.114 0.077 DBMET02122 0.106 0.088 DBMET02123 | ||
| 0.217 | 0.098 | 0.217 | Calpain inhibitor | 0.162 0.161 DBMET02123 | ||
| 0.129 | 0.013 | 0.129 | Alcohol oxidase inhibitor | 0.085 0.022 DBMET02122 0.105 0.017 DBMET02123 | ||
| 0.146 | 0.031 | 0.146 | Caspase 3 inhibitor | 0.097 0.096 DBMET02122 0.139 0.037 DBMET02123 | ||
| 0.15 | 0.038 | 0.176 | Microtubule formation inhibitor | 0.172 0.028 DBMET02122 0.176 0.027 DBMET02123 | DBMET02123 | |
| 0.147 | 0.035 | 0.387 | GABA C receptor agonist | 0.139 0.039 DBMET02122 0.387 0.005 DBMET02123 | DBMET02123 | |
| 0.147 | 0.038 | 0.147 | Falcipain 3 inhibitor | 0.1 0.07 DBMET02122 | ||
| 0.209 | 0.1 | 0.399 | Aldehyde oxidase inhibitor | 0.399 0.047 DBMET02122 0.318 0.062 DBMET02123 | DBMET02122 | |
| 0.111 | 0.003 | 0.119 | Parathyroid hormone antagonist | 0.119 0.003 DBMET02122 0.117 0.003 DBMET02123 | DBMET02122 | |
| 0.111 | 0.003 | 0.206 | Membrane dipeptidase inhibitor | 0.153 0.002 DBMET02122 0.206 0.001 DBMET02123 | DBMET02123 | |
| 0.214 | 0.108 | 0.375 | Interleukin agonist | 0.344 0.031 DBMET02122 0.375 0.023 DBMET02123 | DBMET02123 | |
| 0.203 | 0.098 | 0.61 | Platelet antagonist | 0.352 0.037 DBMET02122 0.61 0.006 DBMET02123 | DBMET02123 | |
| 0.138 | 0.033 | 0.138 | UDP-glucose 4-epimerase inhibitor | 0.115 0.047 DBMET02122 0.087 0.077 DBMET02123 | ||
| 0.15 | 0.046 | 0.15 | Cathepsin H inhibitor | 0.125 0.069 DBMET02123 | ||
| 0.116 | 0.013 | 0.122 | Ornithine carbamoyltransferase inhibitor | 0.122 0.012 DBMET02122 0.118 0.013 DBMET02123 | DBMET02122 | |
| 0.232 | 0.13 | 0.532 | Immunomodulator | 0.532 0.019 DBMET02122 0.523 0.02 DBMET02123 | DBMET02122 | |
| 0.254 | 0.152 | 0.472 | Histamine release inhibitor | 0.47 0.04 DBMET02122 0.472 0.04 DBMET02123 | DBMET02123 | |
| 0.121 | 0.021 | 0.264 | Keratolytic | 0.233 0.006 DBMET02122 0.264 0.005 DBMET02123 | DBMET02123 | |
| 0.137 | 0.04 | 0.278 | Photosensitizer | 0.186 0.016 DBMET02122 0.278 0.005 DBMET02123 | DBMET02123 | |
| 0.117 | 0.02 | 0.153 | Glycine receptor antagonist | 0.122 0.017 DBMET02122 0.153 0.007 DBMET02123 | DBMET02123 | |
| 0.117 | 0.022 | 0.152 | Glutamate decarboxylase inhibitor | 0.085 0.04 DBMET02122 0.152 0.013 DBMET02123 | DBMET02123 | |
| 0.304 | 0.211 | 0.621 | Antiinflammatory | 0.519 0.08 DBMET02122 0.621 0.048 DBMET02123 | DBMET02123 | |
| 0.102 | 0.01 | 0.191 | Glutamate (mGluR6) antagonist | 0.12 0.005 DBMET02122 0.191 0.003 DBMET02123 | DBMET02123 | |
| 0.096 | 0.006 | 0.15 | Squalene synthetase inhibitor | 0.142 0.004 DBMET02122 0.15 0.004 DBMET02123 | DBMET02123 | |
| 0.147 | 0.058 | 0.177 | Pregnane X receptor agonist | 0.177 0.021 DBMET02122 0.166 0.03 DBMET02123 | DBMET02122 | |
| 0.122 | 0.033 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | 0.114 0.04 DBMET02123 | ||
| 0.117 | 0.028 | 0.134 | Ornithine decarboxylase inhibitor | 0.109 0.035 DBMET02122 0.134 0.017 DBMET02123 | DBMET02123 | |
| 0.101 | 0.016 | 0.101 | Cathepsin B inhibitor | |||
| 0.113 | 0.029 | 0.113 | Chymotrypsin inhibitor | 0.077 0.059 DBMET02122 0.096 0.039 DBMET02123 | ||
| 0.164 | 0.081 | 0.245 | Phospholipase C inhibitor | 0.207 0.04 DBMET02122 0.245 0.026 DBMET02123 | DBMET02123 | |
| 0.097 | 0.014 | 0.193 | Interferon inducer | 0.193 0.004 DBMET02122 0.138 0.005 DBMET02123 | DBMET02122 | |
| 0.212 | 0.13 | 0.324 | 5 Hydroxytryptamine uptake stimulant | 0.22 0.117 DBMET02122 0.324 0.034 DBMET02123 | DBMET02123 | |
| 0.192 | 0.111 | 0.399 | Vasodilator | 0.399 0.023 DBMET02122 0.295 0.05 DBMET02123 | DBMET02122 | |
| 0.119 | 0.039 | 0.154 | Prolactin inhibitor | 0.108 0.047 DBMET02122 0.154 0.02 DBMET02123 | DBMET02123 | |
| 0.1 | 0.021 | 0.217 | Carbamoyl phosphate synthetase inhibitor | 0.157 0.01 DBMET02122 0.217 0.007 DBMET02123 | DBMET02123 | |
| 0.106 | 0.026 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 DBMET02122 0.1 0.032 DBMET02123 | ||
| 0.149 | 0.07 | 0.149 | Thiol protease inhibitor | 0.142 0.078 DBMET02122 0.132 0.093 DBMET02123 | ||
| 0.093 | 0.015 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 DBMET02123 | ||
| 0.147 | 0.069 | 0.258 | Cell wall synthesis inhibitor | 0.226 0.021 DBMET02122 0.258 0.014 DBMET02123 | DBMET02123 | |
| 0.094 | 0.018 | 0.113 | CDC25B inhibitor | 0.069 0.038 DBMET02122 0.113 0.012 DBMET02123 | DBMET02123 | |
| 0.112 | 0.039 | 0.141 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.02 DBMET02122 0.141 0.015 DBMET02123 | DBMET02123 | |
| 0.07 | 0.001 | 0.07 | Immunosuppressant Cyclosporine-like | 0.012 0.007 DBMET02122 0.012 0.007 DBMET02123 | ||
| 0.11 | 0.042 | 0.135 | Antineoplastic antibiotic | 0.135 0.034 DBMET02122 0.123 0.038 DBMET02123 | DBMET02122 | |
| 0.142 | 0.076 | 0.192 | Adenylate cyclase stimulant | 0.17 0.035 DBMET02122 0.192 0.017 DBMET02123 | DBMET02123 | |
| 0.078 | 0.012 | 0.091 | Alpha-mannosidase inhibitor | 0.091 0.008 DBMET02122 0.069 0.018 DBMET02123 | DBMET02122 | |
| 0.071 | 0.007 | 0.073 | Geranyltranstransferase inhibitor | 0.073 0.006 DBMET02122 0.062 0.012 DBMET02123 | DBMET02122 | |
| 0.095 | 0.031 | 0.169 | Aminopeptidase I inhibitor | 0.127 0.018 DBMET02122 0.169 0.01 DBMET02123 | DBMET02123 | |
| 0.083 | 0.021 | 0.083 | Caspase 9 inhibitor | 0.083 0.021 DBMET02123 | ||
| 0.064 | 0.004 | 0.064 | Calpain 1 inhibitor | |||
| 0.092 | 0.033 | 0.153 | CDC25A inhibitor | 0.106 0.025 DBMET02122 0.153 0.012 DBMET02123 | DBMET02123 | |
| 0.072 | 0.013 | 0.139 | Adenine nucleotide translocase inhibitor | 0.08 0.009 DBMET02122 0.139 0.003 DBMET02123 | DBMET02123 | |
| 0.091 | 0.034 | 0.213 | GABA aminotransferase inhibitor | 0.094 0.032 DBMET02122 0.213 0.004 DBMET02123 | DBMET02123 | |
| 0.082 | 0.025 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | 0.066 0.042 DBMET02122 0.072 0.035 DBMET02123 | ||
| 0.187 | 0.131 | 0.48 | Spasmolytic | 0.48 0.026 DBMET02122 0.432 0.034 DBMET02123 | DBMET02122 | |
| 0.064 | 0.009 | 0.388 | Fumarate hydratase inhibitor | 0.066 0.009 DBMET02122 0.388 0.002 DBMET02123 | DBMET02123 | |
| 0.126 | 0.075 | 0.126 | NADPH oxidase inhibitor | |||
| 0.066 | 0.016 | 0.142 | Leukocyte elastase inhibitor | 0.082 0.012 DBMET02122 0.142 0.006 DBMET02123 | DBMET02123 | |
| 0.077 | 0.028 | 0.077 | TRPA1 antagonist | |||
| 0.054 | 0.007 | 0.089 | VCAM-1 antagonist | 0.089 0.004 DBMET02122 0.086 0.004 DBMET02123 | DBMET02122 | |
| 0.054 | 0.007 | 0.09 | VCAM antagonist | 0.09 0.004 DBMET02122 0.087 0.004 DBMET02123 | DBMET02122 | |
| 0.075 | 0.029 | 0.123 | Neuraminidase (influenza) inhibitor | 0.123 0.011 DBMET02122 0.082 0.024 DBMET02123 | DBMET02122 | |
| 0.06 | 0.017 | 0.074 | Mannosidase inhibitor | 0.074 0.01 DBMET02122 0.056 0.02 DBMET02123 | DBMET02122 | |
| 0.111 | 0.068 | 0.183 | Monophenol monooxygenase inhibitor | 0.182 0.037 DBMET02122 0.183 0.037 DBMET02123 | DBMET02123 | |
| 0.106 | 0.064 | 0.296 | Ferrochelatase inhibitor | 0.099 0.072 DBMET02122 0.296 0.008 DBMET02123 | DBMET02123 | |
| 0.214 | 0.176 | 0.214 | Calpain 2 inhibitor | |||
| 0.066 | 0.029 | 0.1 | Sphingosine kinase inhibitor | 0.1 0.008 DBMET02122 0.054 0.051 DBMET02123 | DBMET02122 | |
| 0.176 | 0.14 | 0.197 | RNA-directed DNA polymerase inhibitor | 0.197 0.104 DBMET02122 0.191 0.113 DBMET02123 | DBMET02122 | |
| 0.055 | 0.019 | 0.095 | Liver X receptor agonist | 0.095 0.008 DBMET02122 0.073 0.012 DBMET02123 | DBMET02122 | |
| 0.146 | 0.111 | 0.208 | Neurotensin receptor agonist | 0.159 0.082 DBMET02122 0.208 0.031 DBMET02123 | DBMET02123 | |
| 0.049 | 0.015 | 0.078 | Kainate receptor agonist | 0.049 0.014 DBMET02122 0.078 0.004 DBMET02123 | DBMET02123 | |
| 0.096 | 0.061 | 0.162 | Interleukin 12 antagonist | 0.14 0.016 DBMET02122 0.162 0.009 DBMET02123 | DBMET02123 | |
| 0.044 | 0.01 | 0.073 | Prostaglandin D2 agonist | 0.058 0.005 DBMET02122 0.073 0.004 DBMET02123 | DBMET02123 | |
| 0.089 | 0.055 | 0.137 | Androgen antagonist | 0.137 0.026 DBMET02122 0.111 0.039 DBMET02123 | DBMET02122 | |
| 0.064 | 0.031 | 0.064 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.059 0.036 DBMET02122 | ||
| 0.038 | 0.005 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.041 0.004 DBMET02122 0.039 0.004 DBMET02123 | DBMET02122 | |
| 0.052 | 0.02 | 0.063 | AICAR transformylase inhibitor | 0.063 0.013 DBMET02123 | DBMET02123 | |
| 0.036 | 0.005 | 0.116 | Prostacyclin agonist | 0.063 0.004 DBMET02122 0.116 0.003 DBMET02123 | DBMET02123 | |
| 0.037 | 0.006 | 0.076 | Prostaglandin F2 alpha agonist | 0.066 0.003 DBMET02122 0.076 0.003 DBMET02123 | DBMET02123 | |
| 0.071 | 0.04 | 0.232 | Leukotriene antagonist | 0.147 0.01 DBMET02122 0.232 0.005 DBMET02123 | DBMET02123 | |
| 0.114 | 0.085 | 0.181 | Toll-Like receptor 2 antagonist | 0.152 0.051 DBMET02122 0.181 0.033 DBMET02123 | DBMET02123 | |
| 0.047 | 0.018 | 0.06 | GABA uptake inhibitor | 0.06 0.01 DBMET02122 0.052 0.014 DBMET02123 | DBMET02122 | |
| 0.083 | 0.056 | 0.12 | Estrogen-related receptor beta agonist | 0.12 0.01 DBMET02122 0.098 0.027 DBMET02123 | DBMET02122 | |
| 0.057 | 0.032 | 0.138 | Leukotriene B4 antagonist | 0.127 0.006 DBMET02122 0.138 0.005 DBMET02123 | DBMET02123 | |
| 0.205 | 0.18 | 0.373 | Interleukin 2 agonist | 0.342 0.049 DBMET02122 0.373 0.036 DBMET02123 | DBMET02123 | |
| 0.059 | 0.034 | 0.106 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 DBMET02122 0.106 0.015 DBMET02123 | DBMET02123 | |
| 0.029 | 0.004 | 0.092 | Vitamin D receptor agonist | 0.092 0.001 DBMET02122 0.068 0.002 DBMET02123 | DBMET02122 | |
| 0.039 | 0.015 | 0.071 | HMG CoA reductase inhibitor | 0.05 0.007 DBMET02122 0.071 0.004 DBMET02123 | DBMET02123 | |
| 0.062 | 0.038 | 0.096 | Androgen agonist | 0.085 0.021 DBMET02122 0.096 0.016 DBMET02123 | DBMET02123 | |
| 0.038 | 0.014 | 0.171 | ATP citrate lysase inhibitor | 0.041 0.013 DBMET02122 0.171 0.003 DBMET02123 | DBMET02123 | |
| 0.057 | 0.033 | 0.091 | Elastase inhibitor | 0.072 0.02 DBMET02122 0.091 0.012 DBMET02123 | DBMET02123 | |
| 0.118 | 0.095 | 0.273 | Protein kinase stimulant | 0.224 0.034 DBMET02122 0.273 0.021 DBMET02123 | DBMET02123 | |
| 0.074 | 0.053 | 0.098 | Vanilloid 4 agonist | 0.085 0.032 DBMET02122 0.098 0.018 DBMET02123 | DBMET02123 | |
| 0.036 | 0.016 | 0.165 | Prostaglandin agonist | 0.098 0.005 DBMET02122 0.165 0.004 DBMET02123 | DBMET02123 | |
| 0.041 | 0.021 | 0.084 | Arginase inhibitor | 0.065 0.009 DBMET02122 0.084 0.005 DBMET02123 | DBMET02123 | |
| 0.055 | 0.037 | 0.086 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.027 DBMET02122 0.086 0.023 DBMET02123 | DBMET02123 | |
| 0.1 | 0.082 | 0.195 | Anesthetic local | 0.195 0.033 DBMET02122 0.094 0.088 DBMET02123 | DBMET02122 | |
| 0.03 | 0.013 | 0.034 | Hedgehog signaling activator | 0.034 0.007 DBMET02122 0.031 0.011 DBMET02123 | DBMET02122 | |
| 0.056 | 0.039 | 0.086 | Ribonucleotide reductase inhibitor | 0.074 0.029 DBMET02122 0.086 0.024 DBMET02123 | DBMET02123 | |
| 0.154 | 0.137 | 0.196 | MAP kinase kinase 5 inhibitor | 0.196 0.038 DBMET02122 0.154 0.137 DBMET02123 | DBMET02122 | |
| 0.025 | 0.008 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 DBMET02122 0.029 0.005 DBMET02123 | DBMET02122 | |
| 0.02 | 0.004 | 0.02 | 3C-Like protease (MERS coronavirus) inhibitor | |||
| 0.022 | 0.007 | 0.023 | Potassium channel (Inward rectifier) 11 blocker | 0.023 0.006 DBMET02122 0.022 0.007 DBMET02123 | DBMET02122 | |
| 0.07 | 0.055 | 0.094 | Metalloproteinase-9 inhibitor | 0.094 0.035 DBMET02123 | DBMET02123 | |
| 0.044 | 0.029 | 0.064 | Secretase gamma inhibitor | 0.064 0.016 DBMET02122 0.049 0.026 DBMET02123 | DBMET02122 | |
| 0.023 | 0.009 | 0.095 | Toll-Like receptor 8 agonist | 0.095 0.002 DBMET02122 0.024 0.007 DBMET02123 | DBMET02122 | |
| 0.138 | 0.125 | 0.148 | ATPase inhibitor | 0.148 0.104 DBMET02122 | DBMET02122 | |
| 0.021 | 0.008 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET02122 0.022 0.006 DBMET02123 | DBMET02123 | |
| 0.086 | 0.073 | 0.132 | Glutamate release inhibitor | 0.098 0.046 DBMET02122 0.132 0.015 DBMET02123 | DBMET02123 | |
| 0.019 | 0.007 | 0.019 | Antibiotic Macrolide-like | |||
| 0.048 | 0.036 | 0.059 | HCV NS3/NS4A protease inhibitor | 0.059 0.022 DBMET02123 | DBMET02123 | |
| 0.045 | 0.035 | 0.058 | Adenosine deaminase inhibitor | 0.058 0.022 DBMET02122 | DBMET02122 | |
| 0.019 | 0.009 | 0.023 | Telomerase stimulant | 0.021 0.007 DBMET02122 0.023 0.005 DBMET02123 | DBMET02123 | |
| 0.026 | 0.017 | 0.031 | Vanilloid 2 agonist | 0.027 0.014 DBMET02122 0.031 0.008 DBMET02123 | DBMET02123 | |
| 0.095 | 0.086 | 0.123 | DOPA decarboxylase inhibitor | 0.101 0.074 DBMET02122 0.123 0.042 DBMET02123 | DBMET02123 | |
| 0.022 | 0.014 | 0.036 | Neutral endopeptidase inhibitor | 0.036 0.01 DBMET02123 | DBMET02123 | |
| 0.031 | 0.023 | 0.042 | Caspase 2 inhibitor | 0.042 0.015 DBMET02123 | DBMET02123 | |
| 0.029 | 0.022 | 0.062 | Peptide deformylase inhibitor | 0.036 0.017 DBMET02122 0.062 0.006 DBMET02123 | DBMET02123 | |
| 0.023 | 0.016 | 0.059 | ICAM 1 antagonist | 0.059 0.004 DBMET02122 0.038 0.005 DBMET02123 | DBMET02122 | |
| 0.031 | 0.025 | 0.062 | Glutamate (mGluR3) agonist | 0.037 0.013 DBMET02122 0.062 0.004 DBMET02123 | DBMET02123 | |
| 0.047 | 0.04 | 0.089 | Squalene epoxidase inhibitor | 0.089 0.007 DBMET02122 0.052 0.031 DBMET02123 | DBMET02122 | |
| 0.064 | 0.058 | 0.102 | MDM2 inhibitor | 0.094 0.009 DBMET02122 0.102 0.006 DBMET02123 | DBMET02123 | |
| 0.055 | 0.05 | 0.127 | Neuraminidase inhibitor | 0.127 0.009 DBMET02122 0.068 0.035 DBMET02123 | DBMET02122 | |
| 0.063 | 0.057 | 0.063 | Elastase 1 inhibitor | |||
| 0.007 | 0.002 | 0.01 | Vitamin D-like | 0.01 0.001 DBMET02122 0.008 0.002 DBMET02123 | DBMET02122 | |
| 0.079 | 0.073 | 0.136 | Vanilloid agonist | 0.136 0.013 DBMET02122 0.116 0.021 DBMET02123 | DBMET02122 | |
| 0.083 | 0.078 | 0.083 | 5-Lipoxygenase inhibitor | |||
| 0.043 | 0.038 | 0.056 | Microtubule stabilization | 0.053 0.024 DBMET02122 0.056 0.019 DBMET02123 | DBMET02123 | |
| 0.025 | 0.021 | 0.025 | Cathepsin K inhibitor | |||
| 0.08 | 0.077 | 0.088 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.059 DBMET02122 0.088 0.055 DBMET02123 | DBMET02123 | |
| 0.019 | 0.018 | 0.067 | Prostaglandin EP2 agonist | 0.046 0.006 DBMET02122 0.067 0.004 DBMET02123 | DBMET02123 | |
| 0.033 | 0.032 | 0.063 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.063 0.006 DBMET02122 0.034 0.032 DBMET02123 | DBMET02122 | |
| 0.063 | 0.063 | 0.109 | Cathepsin G inhibitor | 0.109 0.03 DBMET02123 | DBMET02123 | |
| 0.024 | 0.024 | 0.029 | Nicotinic acid receptor 2 antagonist | 0.025 0.023 DBMET02122 0.029 0.014 DBMET02123 | DBMET02123 | |
| 0.038 | 0.039 | 0.045 | HIV-1 protease inhibitor | 0.045 0.027 DBMET02122 0.044 0.029 DBMET02123 | DBMET02122 | |
| 0.045 | 0.046 | 0.068 | Cytokine production stimulant | 0.068 0.008 DBMET02122 0.048 0.034 DBMET02123 | DBMET02122 | |
| 0.132 | 0.133 | 0.271 | Psychostimulant | 0.241 0.062 DBMET02122 0.271 0.051 DBMET02123 | DBMET02123 | |
| 0.034 | 0.037 | 0.069 | Glutamate (mGluR8) agonist | 0.069 0.005 DBMET02123 | DBMET02123 | |
| 0.09 | 0.093 | 0.167 | Mucolytic | 0.149 0.033 DBMET02122 0.167 0.024 DBMET02123 | DBMET02123 | |
| 0.02 | 0.023 | 0.032 | Isoleucine-tRNA ligase inhibitor | 0.032 0.005 DBMET02122 0.03 0.005 DBMET02123 | DBMET02122 | |
| 0.062 | 0.065 | 0.176 | Porphobilinogen synthase inhibitor | 0.176 0.015 DBMET02123 | DBMET02123 | |
| 0.053 | 0.056 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 DBMET02122 0.063 0.029 DBMET02123 | DBMET02122 | |
| 0.139 | 0.143 | 0.533 | Anticonvulsant | 0.238 0.062 DBMET02122 0.533 0.01 DBMET02123 | DBMET02123 | |
| 0.23 | 0.235 | 0.701 | Cyclophilin D inhibitor | 0.575 0.032 DBMET02122 0.701 0.014 DBMET02123 | DBMET02123 | |
| 0.029 | 0.034 | 0.049 | Carboxypeptidase B inhibitor | 0.032 0.024 DBMET02122 0.049 0.007 DBMET02123 | DBMET02123 | |
| 0.017 | 0.022 | 0.02 | Caspase 8 inhibitor | 0.02 0.012 DBMET02123 | DBMET02123 | |
| 0.071 | 0.078 | 0.138 | Glutathione S-transferase inhibitor | 0.138 0.015 DBMET02122 0.117 0.024 DBMET02123 | DBMET02122 | |
| 0.021 | 0.028 | 0.068 | Lysine carboxypeptidase inhibitor | 0.03 0.016 DBMET02122 0.068 0.005 DBMET02123 | DBMET02123 | |
| 0.026 | 0.034 | 0.102 | Retinoid X receptor agonist | 0.037 0.024 DBMET02122 0.102 0.004 DBMET02123 | DBMET02123 | |
| 0.02 | 0.028 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 DBMET02122 | DBMET02122 | |
| 0.031 | 0.039 | 0.036 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 DBMET02122 0.036 0.019 DBMET02123 | DBMET02123 | |
| 0.012 | 0.02 | 0.031 | Aminopeptidase A inhibitor | 0.031 0.006 DBMET02123 | DBMET02123 | |
| 0.078 | 0.086 | 0.188 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET02122 0.188 0.018 DBMET02123 | DBMET02123 | |
| 0.068 | 0.077 | 0.113 | GABA B receptor agonist | 0.094 0.021 DBMET02122 0.113 0.01 DBMET02123 | DBMET02123 | |
| 0.079 | 0.089 | 0.168 | Sphingomyelinase inhibitor | 0.168 0.018 DBMET02122 0.092 0.07 DBMET02123 | DBMET02122 | |
| 0.02 | 0.031 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DBMET02122 0.029 0.012 DBMET02123 | DBMET02122 | |
| 0.025 | 0.036 | 0.04 | Calcitonin receptor agonist | 0.033 0.024 DBMET02122 0.04 0.02 DBMET02123 | DBMET02123 | |
| 0.118 | 0.13 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | 0.166 0.038 DBMET02122 0.167 0.037 DBMET02123 | DBMET02123 | |
| 0.042 | 0.053 | 0.047 | Prolyl endopeptidase inhibitor | 0.047 0.04 DBMET02123 | DBMET02123 | |
| 0.04 | 0.053 | 0.087 | Diacylglycerol O-acyltransferase inhibitor | 0.072 0.018 DBMET02122 0.087 0.011 DBMET02123 | DBMET02123 | |
| 0.058 | 0.071 | 0.081 | Glutamate (mGluR7) antagonist | 0.081 0.026 DBMET02123 | DBMET02123 | |
| 0.035 | 0.049 | 0.056 | Antimetabolite | 0.048 0.033 DBMET02122 0.056 0.027 DBMET02123 | DBMET02123 | |
| 0.007 | 0.025 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DBMET02122 | DBMET02122 | |
| 0.042 | 0.06 | 0.069 | CD45 antagonist | 0.069 0.015 DBMET02123 | DBMET02123 | |
| 0.109 | 0.127 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | 0.15 0.041 DBMET02122 0.16 0.03 DBMET02123 | DBMET02123 | |
| 0.01 | 0.028 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 DBMET02123 | DBMET02123 | |
| 0.01 | 0.028 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 DBMET02123 | DBMET02123 | |
| 0.03 | 0.049 | 0.096 | Endothelin-converting enzyme inhibitor | 0.042 0.036 DBMET02122 0.096 0.015 DBMET02123 | DBMET02123 | |
| 0.016 | 0.035 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET02123 | DBMET02123 | |
| 0.042 | 0.061 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.057 0.033 DBMET02122 | DBMET02122 | |
| 0.006 | 0.026 | 0.063 | Prostaglandin EP4 agonist | 0.063 0.004 DBMET02123 | DBMET02123 | |
| 0.015 | 0.035 | 0.059 | CC chemokine 1 receptor antagonist | 0.059 0.006 DBMET02122 0.022 0.018 DBMET02123 | DBMET02122 | |
| 0.085 | 0.105 | 0.128 | GABA C receptor antagonist | 0.107 0.068 DBMET02122 0.128 0.045 DBMET02123 | DBMET02123 | |
| 0.013 | 0.037 | 0.051 | Prostaglandin E2 agonist | 0.028 0.012 DBMET02122 0.051 0.005 DBMET02123 | DBMET02123 | |
| 0.122 | 0.146 | 0.373 | Interleukin antagonist | 0.318 0.044 DBMET02122 0.373 0.035 DBMET02123 | DBMET02123 | |
| 0.021 | 0.046 | 0.104 | Peroxisome proliferator-activated receptor delta agonist | 0.036 0.02 DBMET02122 0.104 0.005 DBMET02123 | DBMET02123 | |
| 0.015 | 0.04 | 0.133 | Leukotriene D4 antagonist | 0.025 0.019 DBMET02122 0.133 0.005 DBMET02123 | DBMET02123 | |
| 0.004 | 0.03 | 0.014 | Carboxypeptidase B2 inhibitor | 0.014 0.006 DBMET02123 | DBMET02123 | |
| 0.01 | 0.035 | 0.018 | Thromboxane A2 agonist | 0.018 0.007 DBMET02123 | DBMET02123 | |
| 0.042 | 0.068 | 0.052 | Factor III inhibitor | 0.052 0.029 DBMET02122 | DBMET02122 | |
| 0.132 | 0.159 | 0.241 | Insulin sensitizer | 0.186 0.088 DBMET02122 0.241 0.04 DBMET02123 | DBMET02123 | |
| 0.022 | 0.049 | 0.073 | Liver X receptor beta agonist | 0.073 0.006 DBMET02122 0.045 0.012 DBMET02123 | DBMET02122 | |
| 0.071 | 0.099 | 0.101 | NADH dehydrogenase inhibitor | 0.095 0.049 DBMET02122 0.101 0.043 DBMET02123 | DBMET02123 | |
| 0.031 | 0.059 | 0.059 | Matrix metalloproteinase 1 inhibitor | 0.046 0.041 DBMET02122 0.059 0.032 DBMET02123 | DBMET02123 | |
| 0.07 | 0.1 | 0.098 | Alcohol dehydrogenase inhibitor | 0.098 0.054 DBMET02122 0.089 0.066 DBMET02123 | DBMET02122 | |
| 0.005 | 0.035 | 0.034 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.034 0.005 DBMET02123 | DBMET02123 | |
| 0.026 | 0.056 | 0.041 | Oxytocin agonist | 0.041 0.031 DBMET02122 | DBMET02122 | |
| 0.056 | 0.088 | 0.073 | Exportin-1 inhibitor | 0.073 0.036 DBMET02123 | DBMET02123 | |
| 0.077 | 0.108 | 0.217 | Protein-tyrosine phosphatase 1B inhibitor | 0.138 0.051 DBMET02122 0.217 0.025 DBMET02123 | DBMET02123 | |
| 0.044 | 0.076 | 0.101 | Matrix metalloproteinase inhibitor | 0.074 0.041 DBMET02122 0.101 0.026 DBMET02123 | DBMET02123 | |
| 0.036 | 0.069 | 0.066 | Aminopeptidase microsomal inhibitor | 0.066 0.034 DBMET02123 | DBMET02123 | |
| 0.041 | 0.074 | 0.086 | Sphingosine kinase 2 inhibitor | 0.086 0.012 DBMET02122 | DBMET02122 | |
| 0.011 | 0.045 | 0.025 | 5-Alpha-reductase 2 inhibitor | 0.025 0.01 DBMET02123 | DBMET02123 | |
| 0.04 | 0.074 | 0.11 | Biliverdin reductase inhibitor | 0.11 0.016 DBMET02123 | DBMET02123 | |
| 0.004 | 0.039 | 0.011 | Thromboxane agonist | 0.011 0.007 DBMET02123 | DBMET02123 | |
| 0.005 | 0.04 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.008 DBMET02123 | DBMET02123 | |
| 0.016 | 0.051 | 0.034 | Renin inhibitor | 0.034 0.028 DBMET02122 | DBMET02122 | |
| 0.046 | 0.081 | 0.055 | Pregnane X receptor antagonist | 0.055 0.044 DBMET02123 | DBMET02123 | |
| 0.041 | 0.077 | 0.114 | Carbonic anhydrase stimulant | 0.114 0.015 DBMET02123 | DBMET02123 | |
| 0.02 | 0.058 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 DBMET02122 0.025 0.022 DBMET02123 | DBMET02122 | |
| 0.023 | 0.062 | 0.102 | Peroxisome proliferator-activated receptor delta antagonist | 0.037 0.018 DBMET02122 0.102 0.005 DBMET02123 | DBMET02123 | |
| 0.007 | 0.048 | 0.081 | Free fatty acid receptor 1 agonist | 0.016 0.015 DBMET02122 0.081 0.004 DBMET02123 | DBMET02123 | |
| 0.014 | 0.056 | 0.053 | Prostaglandin EP4 antagonist | 0.053 0.008 DBMET02123 | DBMET02123 | |
| 0.04 | 0.083 | 0.081 | Neutrophil collagenase inhibitor | 0.081 0.031 DBMET02123 | DBMET02123 | |
| 0.029 | 0.072 | 0.056 | Metalloproteinase-3 inhibitor | 0.056 0.027 DBMET02123 | DBMET02123 | |
| 0.006 | 0.049 | 0.013 | Calcium-dependent phospholipase A2 inhibitor | 0.013 0.008 DBMET02123 | DBMET02123 | |
| 0.012 | 0.057 | 0.049 | Leukotriene B4 receptor 1 antagonist | 0.038 0.013 DBMET02122 0.049 0.007 DBMET02123 | DBMET02123 | |
| 0.03 | 0.075 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.018 DBMET02122 0.043 0.036 DBMET02123 | DBMET02122 | |
| 0.022 | 0.068 | 0.047 | Toll-Like receptor 2 agonist | 0.038 0.032 DBMET02122 0.047 0.025 DBMET02123 | DBMET02123 | |
| 0.026 | 0.072 | 0.049 | Glutamate (mGluR8) antagonist | 0.049 0.009 DBMET02123 | DBMET02123 | |
| 0.107 | 0.153 | 0.305 | Angiogenesis stimulant | 0.305 0.047 DBMET02122 0.302 0.048 DBMET02123 | DBMET02122 | |
| 0.12 | 0.167 | 0.254 | P-glycoprotein inhibitor | 0.254 0.04 DBMET02122 0.204 0.062 DBMET02123 | DBMET02122 | |
| 0.04 | 0.087 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.041 DBMET02122 | DBMET02122 | |
| 0.155 | 0.203 | 0.195 | Transcription factor STAT3 inhibitor | 0.195 0.141 DBMET02123 | DBMET02123 | |
| 0.033 | 0.081 | 0.055 | Collagenase inhibitor | 0.055 0.023 DBMET02123 | DBMET02123 | |
| 0.028 | 0.077 | 0.041 | Neurotensin receptor antagonist | 0.041 0.035 DBMET02123 | DBMET02123 | |
| 0.077 | 0.126 | 0.125 | Alkylator | 0.125 0.064 DBMET02122 0.1 0.088 DBMET02123 | DBMET02122 | |
| 0.023 | 0.073 | 0.055 | Glutamate (mGluR3) antagonist | 0.055 0.01 DBMET02123 | DBMET02123 | |
| 0.066 | 0.118 | 0.2 | Gastric antisecretory | 0.19 0.014 DBMET02122 0.2 0.012 DBMET02123 | DBMET02123 | |
| 0.025 | 0.076 | 0.048 | Liver X receptor alpha agonist | 0.043 0.026 DBMET02122 0.048 0.021 DBMET02123 | DBMET02123 | |
| 0.012 | 0.064 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | 0.022 0.013 DBMET02123 | DBMET02123 | |
| 0.008 | 0.06 | 0.04 | Prostaglandin H2 antagonist | 0.023 0.02 DBMET02122 0.04 0.006 DBMET02123 | DBMET02123 | |
| 0.132 | 0.185 | 0.325 | Tumour necrosis factor alpha release inhibitor | 0.301 0.053 DBMET02122 0.325 0.045 DBMET02123 | DBMET02123 | |
| 0.023 | 0.076 | 0.084 | Peroxisome proliferator-activated receptor alpha agonist | 0.042 0.04 DBMET02122 0.084 0.016 DBMET02123 | DBMET02123 | |
| 0.037 | 0.091 | 0.075 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.075 0.027 DBMET02123 | DBMET02123 | |
| 0.042 | 0.096 | 0.121 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.035 DBMET02122 0.121 0.018 DBMET02123 | DBMET02123 | |
| 0.035 | 0.089 | 0.05 | Bombesin 2 receptor antagonist | 0.05 0.033 DBMET02123 | DBMET02123 | |
| 0.005 | 0.059 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | 0.021 0.015 DBMET02123 | DBMET02123 | |
| 0.017 | 0.071 | 0.029 | Methionyl aminopeptidase 1 inhibitor | 0.029 0.027 DBMET02123 | DBMET02123 | |
| 0.066 | 0.121 | 0.145 | Expectorant | 0.121 0.05 DBMET02122 0.145 0.037 DBMET02123 | DBMET02123 | |
| 0.082 | 0.138 | 0.151 | Cyclooxygenase 3 inhibitor | 0.136 0.061 DBMET02122 0.151 0.047 DBMET02123 | DBMET02123 | |
| 0.023 | 0.079 | 0.043 | Aminopeptidase N inhibitor | 0.043 0.039 DBMET02123 | DBMET02123 | |
| 0.117 | 0.174 | 0.247 | Lipocortins synthesis antagonist | 0.149 0.107 DBMET02122 0.247 0.034 DBMET02123 | DBMET02123 | |
| 0.061 | 0.118 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.091 0.064 DBMET02122 0.134 0.032 DBMET02123 | DBMET02123 | |
| 0.054 | 0.113 | 0.086 | Peroxisome proliferator-activated receptor gamma antagonist | 0.086 0.026 DBMET02123 | DBMET02123 | |
| 0.125 | 0.185 | 0.221 | Free radical scavenger | 0.221 0.082 DBMET02123 | DBMET02123 | |
| 0.029 | 0.089 | 0.158 | Prostaglandin EP2 antagonist | 0.158 0.009 DBMET02123 | DBMET02123 | |
| 0.014 | 0.074 | 0.049 | Kainate receptor 2 antagonist | 0.049 0.016 DBMET02123 | DBMET02123 | |
| 0.029 | 0.09 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | 0.054 0.029 DBMET02122 0.058 0.025 DBMET02123 | DBMET02123 | |
| 0.022 | 0.082 | 0.058 | p53 inhibitor | 0.039 0.021 DBMET02122 0.058 0.01 DBMET02123 | DBMET02123 | |
| 0.012 | 0.073 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.02 DBMET02123 | DBMET02123 | |
| 0.015 | 0.077 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 DBMET02123 | DBMET02123 | |
| 0.021 | 0.084 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.021 DBMET02123 | DBMET02123 | |
| 0.098 | 0.162 | 0.347 | Insulin secretagoues | 0.24 0.021 DBMET02122 0.347 0.008 DBMET02123 | DBMET02123 | |
| 0.098 | 0.162 | 0.17 | Farnesoid X receptor antagonist | 0.17 0.035 DBMET02122 0.16 0.042 DBMET02123 | DBMET02122 | |
| 0.016 | 0.08 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.021 DBMET02122 | DBMET02122 | |
| 0.049 | 0.114 | 0.114 | Metalloproteinase-2 inhibitor | 0.114 0.032 DBMET02123 | DBMET02123 | |
| 0.014 | 0.079 | 0.048 | 5-Alpha-reductase inhibitor | 0.048 0.019 DBMET02123 | DBMET02123 | |
| 0.024 | 0.089 | 0.041 | Retinoid X receptor antagonist | 0.041 0.021 DBMET02123 | DBMET02123 | |
| 0.01 | 0.077 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.015 DBMET02122 | DBMET02122 | |
| 0.032 | 0.1 | 0.071 | Matrix metalloproteinase (membrane-type) inhibitor | 0.071 0.024 DBMET02123 | DBMET02123 | |
| 0.01 | 0.079 | 0.059 | Prostaglandin EP3 antagonist | 0.059 0.008 DBMET02123 | DBMET02123 | |
| 0.092 | 0.162 | 0.239 | Protein-tyrosine phosphatase inhibitor | 0.153 0.075 DBMET02122 0.239 0.034 DBMET02123 | DBMET02123 | |
| 0.025 | 0.096 | 0.054 | Sphingosine kinase 1 inhibitor | 0.054 0.013 DBMET02122 | DBMET02122 | |
| 0.015 | 0.095 | 0.039 | Retinoid X alpha receptor agonist | 0.039 0.02 DBMET02123 | DBMET02123 | |
| 0.014 | 0.097 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.017 DBMET02122 | DBMET02122 | |
| 0.145 | 0.23 | 0.169 | Nitric-oxide synthase stimulant | 0.169 0.154 DBMET02122 0.167 0.16 DBMET02123 | DBMET02122 | |
| 0.056 | 0.143 | 0.098 | Creatine kinase inhibitor | 0.098 0.061 DBMET02122 0.091 0.07 DBMET02123 | DBMET02122 | |
| 0.036 | 0.123 | 0.065 | Histidine decarboxylase inhibitor | 0.065 0.056 DBMET02123 | DBMET02123 | |
| 0.167 | 0.258 | 0.228 | GABA C receptor rho-3 antagonist | 0.228 0.175 DBMET02123 | DBMET02123 | |
| 0.033 | 0.125 | 0.074 | Thromboxane synthase inhibitor | 0.053 0.04 DBMET02122 0.074 0.015 DBMET02123 | DBMET02123 | |
| 0.041 | 0.134 | 0.115 | Calcium antagonist | 0.115 0.038 DBMET02122 | DBMET02122 | |
| 0.062 | 0.155 | 0.093 | GABA C receptor rho-1 antagonist | 0.093 0.073 DBMET02123 | DBMET02123 | |
| 0.059 | 0.154 | 0.115 | Cystathionine beta-synthase inhibitor | 0.115 0.062 DBMET02123 | DBMET02123 | |
| 0.062 | 0.157 | 0.165 | DNA polymerase I inhibitor | 0.111 0.075 DBMET02122 0.165 0.042 DBMET02123 | DBMET02123 | |
| 0.035 | 0.133 | 0.065 | Angiotensin-converting enzyme inhibitor | 0.065 0.025 DBMET02123 | DBMET02123 | |
| 0.067 | 0.168 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.072 DBMET02122 | DBMET02122 | |
| 0.04 | 0.144 | 0.059 | Leukotriene C antagonist | 0.059 0.031 DBMET02123 | DBMET02123 | |
| 0.026 | 0.13 | 0.087 | Integrin alpha1beta1 antagonist | 0.087 0.003 DBMET02123 | DBMET02123 | |
| 0.065 | 0.171 | 0.126 | Toll-Like receptor 4 antagonist | 0.097 0.075 DBMET02122 0.126 0.038 DBMET02123 | DBMET02123 | |
| 0.034 | 0.145 | 0.084 | NMDA receptor agonist | 0.084 0.026 DBMET02123 | DBMET02123 | |
| 0.016 | 0.127 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.017 DBMET02122 | DBMET02122 | |
| 0.068 | 0.179 | 0.285 | Thrombolytic | 0.132 0.097 DBMET02122 0.285 0.026 DBMET02123 | DBMET02123 | |
| 0.026 | 0.14 | 0.038 | Leukotriene C4 antagonist | 0.038 0.03 DBMET02123 | DBMET02123 | |
| 0.019 | 0.134 | 0.055 | Carbonic anhydrase XIV inhibitor | 0.055 0.028 DBMET02123 | DBMET02123 | |
| 0.063 | 0.179 | 0.092 | T cell inhibitor | 0.092 0.034 DBMET02123 | DBMET02123 | |
| 0.089 | 0.21 | 0.256 | Hemostatic | 0.17 0.049 DBMET02122 0.256 0.021 DBMET02123 | DBMET02123 | |
| 0.029 | 0.153 | 0.049 | Carbonic anhydrase II stimulant | 0.049 0.042 DBMET02123 | DBMET02123 | |
| 0.024 | 0.148 | 0.06 | Selectin antagonist | 0.055 0.054 DBMET02122 0.06 0.049 DBMET02123 | DBMET02123 | |
| 0.117 | 0.242 | 0.367 | Hypoglycemic | 0.254 0.075 DBMET02122 0.367 0.034 DBMET02123 | DBMET02123 | |
| 0.015 | 0.14 | 0.116 | Macrophage elastase inhibitor | 0.116 0.008 DBMET02123 | DBMET02123 | |
| 0.025 | 0.151 | 0.141 | Peroxisome proliferator-activated receptor gamma agonist | 0.081 0.04 DBMET02122 0.141 0.015 DBMET02123 | DBMET02123 | |
| 0.021 | 0.148 | 0.044 | Thymidine kinase inhibitor | 0.044 0.024 DBMET02122 | DBMET02122 | |
| 0.086 | 0.213 | 0.289 | Growth hormone agonist | 0.129 0.109 DBMET02122 0.289 0.034 DBMET02123 | DBMET02123 | |
| 0.021 | 0.151 | 0.057 | Maillard reaction inhibitor | 0.057 0.037 DBMET02123 | DBMET02123 | |
| 0.013 | 0.144 | 0.033 | Growth factor receptor-bound protein 2 antagonist | 0.033 0.029 DBMET02123 | DBMET02123 | |
| 0.076 | 0.216 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | 0.107 0.103 DBMET02123 | DBMET02123 | |
| 0.014 | 0.156 | 0.055 | Phosphodiesterase 2A inhibitor | 0.055 0.028 DBMET02122 | DBMET02122 | |
| 0.017 | 0.162 | 0.035 | Cholecystokinin B agonist | 0.035 0.03 DBMET02123 | DBMET02123 | |
| 0.01 | 0.157 | 0.025 | Retinoid X gamma receptor antagonist | 0.025 0.024 DBMET02123 | DBMET02123 | |
| 0.07 | 0.217 | 0.135 | Anticoagulant | 0.135 0.094 DBMET02123 | DBMET02123 | |
| 0.024 | 0.174 | 0.042 | Glutamate (mGluR group III) antagonist | 0.042 0.035 DBMET02123 | DBMET02123 | |
| 0.008 | 0.16 | 0.034 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET02123 | DBMET02123 | |
| 0.012 | 0.164 | 0.063 | Phosphodiesterase II inhibitor | 0.063 0.029 DBMET02122 | DBMET02122 | |
| 0.012 | 0.169 | 0.048 | Cannabinoid CB2 receptor antagonist | 0.048 0.038 DBMET02122 | DBMET02122 | |
| 0.134 | 0.293 | 0.243 | Insulysin inhibitor | 0.243 0.103 DBMET02123 | DBMET02123 | |
| 0.02 | 0.183 | 0.072 | Prostaglandin-E synthase inhibitor | 0.072 0.046 DBMET02123 | DBMET02123 | |
| 0.05 | 0.216 | 0.085 | Carbonic anhydrase III inhibitor | 0.085 0.082 DBMET02123 | DBMET02123 | |
| 0.016 | 0.184 | 0.059 | Thromboxane antagonist | 0.059 0.033 DBMET02123 | DBMET02123 | |
| 0.077 | 0.247 | 0.152 | Platelet adhesion inhibitor | 0.152 0.103 DBMET02123 | DBMET02123 | |
| 0.013 | 0.185 | 0.067 | Prostaglandin E2 antagonist | 0.067 0.025 DBMET02123 | DBMET02123 | |
| 0.039 | 0.211 | 0.127 | Mediator release inhibitor | 0.127 0.042 DBMET02122 0.116 0.051 DBMET02123 | DBMET02122 | |
| 0.013 | 0.188 | 0.054 | Thromboxane A2 antagonist | 0.054 0.033 DBMET02123 | DBMET02123 | |
| 0.007 | 0.182 | 0.027 | Glucagon receptor antagonist | 0.027 0.023 DBMET02123 | DBMET02123 | |
| 0.009 | 0.19 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.032 DBMET02123 | DBMET02123 | |
| 0.108 | 0.293 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.102 DBMET02123 | DBMET02123 | |
| 0.021 | 0.209 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DBMET02122 | DBMET02122 | |
| 0.044 | 0.235 | 0.098 | Bile acid receptor antagonist | 0.086 0.084 DBMET02122 0.098 0.054 DBMET02123 | DBMET02123 | |
| 0.019 | 0.215 | 0.058 | Collagenase 3 inhibitor | 0.058 0.043 DBMET02123 | DBMET02123 | |
| 0.045 | 0.246 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.071 DBMET02122 | DBMET02122 | |
| 0.072 | 0.288 | 0.265 | Interleukin 6 antagonist | 0.265 0.02 DBMET02122 | DBMET02122 | |
| 0.036 | 0.253 | 0.141 | Bronchodilator | 0.141 0.035 DBMET02122 | DBMET02122 | |
| 0.05 | 0.289 | 0.091 | Hematopoietic | 0.091 0.048 DBMET02123 | DBMET02123 | |
| 0.049 | 0.309 | 0.134 | Dual specificity phosphatase 3 inhibitor | 0.134 0.111 DBMET02123 | DBMET02123 | |
| 0.106 | 0.371 | 0.346 | Sodium/bile acid cotransporter inhibitor | 0.214 0.169 DBMET02122 0.346 0.042 DBMET02123 | DBMET02123 | |
| 0.048 | 0.329 | 0.136 | Dual specificity phosphatase inhibitor | 0.136 0.112 DBMET02123 | DBMET02123 | |
| 0.02 | 0.316 | 0.079 | Prostaglandin F2 alpha antagonist | 0.079 0.024 DBMET02123 | DBMET02123 | |
| 0.058 | 0.356 | 0.171 | Antipruritic | 0.171 0.073 DBMET02122 0.162 0.082 DBMET02123 | DBMET02122 | |
| 0.102 | 0.413 | 0.185 | Peptidyltransferase inhibitor | 0.185 0.121 DBMET02122 | DBMET02122 | |
| 0.078 | 0.399 | 0.163 | Growth factor agonist | 0.163 0.115 DBMET02122 | DBMET02122 | |
| 0.051 | 0.375 | 0.135 | Folate antagonist | 0.135 0.029 DBMET02123 | DBMET02123 | |
| 0.008 | 0.35 | 0.108 | Prostaglandin antagonist | 0.108 0.016 DBMET02123 | DBMET02123 | |
| 0.011 | 0.357 | 0.056 | Glucagon-like peptide 1 agonist | 0.056 0.051 DBMET02123 | DBMET02123 | |
| 0.005 | 0.375 | 0.031 | Prostacyclin antagonist | 0.031 0.024 DBMET02123 | DBMET02123 | |
| 0.032 | 0.404 | 0.105 | Nav1.4 sodium channel blocker | 0.105 0.068 DBMET02123 | DBMET02123 | |
| 0.017 | 0.416 | 0.06 | Cyclin H inhibitor | 0.06 0.04 DBMET02122 | DBMET02122 | |
| 0.004 | 0.409 | 0.077 | GP IIb/IIIa receptor antagonist | 0.077 0.022 DBMET02123 | DBMET02123 | |
| 0.003 | 0.414 | 0.017 | Integrin beta3 antagonist | 0.017 0.016 DBMET02123 | DBMET02123 | |
| 0.056 | 0.503 | 0.306 | Antiobesity | 0.244 0.162 DBMET02122 0.306 0.112 DBMET02123 | DBMET02123 | |
| 0.027 | 0.514 | 0.321 | Cell adhesion inhibitor | 0.321 0.009 DBMET02123 | DBMET02123 | |
| 0.009 | 0.512 | 0.042 | Estrogen-related receptor beta antagonist | 0.042 0.009 DBMET02122 | DBMET02122 | |
| 0.012 | 0.537 | 0.139 | Diuretic | 0.139 0.087 DBMET02123 | DBMET02123 | |
| 0.013 | 0.547 | 0.227 | Cell adhesion molecule inhibitor | 0.227 0.008 DBMET02123 | DBMET02123 | |
| 0.008 | 0.584 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.058 0.028 DBMET02123 | DBMET02123 | |
| 0.004 | 0.601 | 0.017 | Integrin beta6 antagonist | 0.017 0.005 DBMET02123 | DBMET02123 | |
| 0.004 | 0.614 | 0.02 | Integrin beta5 antagonist | 0.02 0.016 DBMET02123 | DBMET02123 | |
| 0.026 | 0.701 | 0.385 | Toll-Like receptor agonist | 0.234 0.163 DBMET02122 0.385 0.067 DBMET02123 | DBMET02123 | |
| 0.025 | 0.71 | 0.368 | Toll-Like receptor 7 agonist | 0.212 0.187 DBMET02122 0.368 0.074 DBMET02123 | DBMET02123 | |
| 0.004 | 0.694 | 0.021 | Integrin alphaVbeta1 antagonist | 0.021 0.011 DBMET02123 | DBMET02123 | |
| 0.003 | 0.711 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.018 DBMET02123 | DBMET02123 | |
| 0.004 | 0.738 | 0.058 | Integrin antagonist | 0.058 0.025 DBMET02123 | DBMET02123 | |
| 0.023 | 0.762 | 0.28 | Analgesic | 0.28 0.157 DBMET02123 | DBMET02123 | |
| 0.006 | 0.847 | 0.172 | Platelet aggregation inhibitor | 0.172 0.105 DBMET02123 | DBMET02123 | |
| 0.009 | 0.955 | 0.134 | MAP3K9 inhibitor | 0.134 0.087 DBMET02122 | DBMET02122 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |